Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose theophylline and prednisone for COPD exacerbations
NCT02261727Phase 4Completed
- Sponsor
- The George Institute for Global Health
- Start
- Jun 2014
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of theophylline and prednisone in chronic obstructive pulmonary disease (COPD), sponsored by The George Institute for Global Health. Started Jun 2014; status: completed.
02
Drugs
theophyllineprednisone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02261727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02261727.